This article was originally published in The Gray Sheet
"Medical Device Update '98" meeting is planned for June 24-25 in Washington, D.C. Among the topics to be addressed by FDAers are: accelerated approvals and reviews (Susan Alpert, director, ODE); quality system regulation (Kimberly Trautman, Good Manufacturing Practices/Quality Systems Expert, Office of Compliance); international harmonization (Larry Kessler, director, Office of Surveillance and Biometrics); postmarket requirements (Thomas Gross, director, Division of Postmarket Surveillance, OSB); and refurbishers (Casper Uldricks, special assistant to the director, OC). For more information call 1/800-956-6293...
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.